AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Krystal Biotech, Inc. Director's Dealing 2021

May 12, 2021

31006_dirs_2021-05-11_31bb1582-615d-4bb9-a40d-328091b3823a.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Krystal Biotech, Inc. (KRYS)
CIK: 0001711279
Period of Report: 2021-05-01

Reporting Person: ORTH ANDREW C. (Chief Commercial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	100	Direct

Footnotes

F1: Represents common stock acquired prior to employment with Krystal Biotech, Inc.